Current opinion on the diagnosis and management of non-functioning pituitary adenomas

被引:3
|
作者
Lamback, Elisa B. [1 ,2 ,3 ,4 ]
Wildemberg, Luiz Eduardo [1 ,2 ,3 ,4 ]
Gadelha, Monica R. [1 ,2 ,3 ,4 ]
机构
[1] Neuroendocrinol Res Ctr, Div Endocrinol, Sch Med, Rio De Janeiro, Brazil
[2] Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil
[3] Inst Estadual Cerebro Paulo Niemeyer, Neuropathol & Mol Genet Lab, Rio De Janeiro, Brazil
[4] Inst Estadual Cerebro Paulo Niemeyer, Neuroendocrine Unit, Rio De Janeiro, Brazil
关键词
Biomarkers; immunohistochemistry; molecular biology; pituitary adenoma; pangenomic classification; who classification; QUALITY-OF-LIFE; MICROSCOPIC TRANSSPHENOIDAL SURGERY; NATURAL-HISTORY; NEUROENDOCRINE-TUMORS; SILENT; EXPRESSION; CLASSIFICATION; EPIDEMIOLOGY; TEMOZOLOMIDE; ASSOCIATION;
D O I
10.1080/17446651.2021.1988851
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Non-functioning pituitary adenomas (NFPAs) are clinically silent tumors and the second most common pituitary adenoma. Surgery is the mainstay of treatment as there is, as yet, no effective medical treatment. Areas covered We present current knowledge on the clinical diagnosis, histopathological classification, molecular data, and management strategies in NFPA. Expert opinion NFPA is a heterogeneous group of tumors, in respect to their origin and clinical course. In recent years, research on pathology and molecular biology have advanced our knowledge of NFPA pathogenesis. NFPA exhibit, in the majority of cases, an indolent behavior, with satisfactory response to treatment. In aggressive cases, multimodal management is needed; however, even this approach may be insufficient, so the development of new treatments is warranted for better management. In this setting, the understanding of the mechanisms involved in the genesis and progression of NFPA is crucial for the identification and development of directed treatments with higher chances of response.
引用
收藏
页码:309 / 320
页数:12
相关论文
共 50 条
  • [1] Diagnosis and management of prolactinomas and non-functioning pituitary adenomas
    Rogers, Angela
    Karavitaki, Niki
    Wass, John A. H.
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [2] The management of non-functioning pituitary adenomas
    Jane, JA
    Laws, ER
    NEUROLOGY INDIA, 2003, 51 (04) : 461 - 465
  • [3] Management of non-functioning pituitary adenomas: surgery
    Penn, David L.
    Burke, William T.
    Laws, Edward R.
    PITUITARY, 2018, 21 (02) : 145 - 153
  • [4] Optimal management of non-functioning pituitary adenomas
    Yona Greenman
    Naftali Stern
    Endocrine, 2015, 50 : 51 - 55
  • [5] Surgical Management of Non-functioning Pituitary Adenomas
    Ciubotaru, V
    Tataranu, L.
    Paunescu, D.
    Dricu, A.
    PAPERS PRESENTED AT THE EANS ANNUAL MEETING, 2012, : 53 - 59
  • [6] Management of non-functioning pituitary adenomas: surgery
    David L. Penn
    William T. Burke
    Edward R. Laws
    Pituitary, 2018, 21 : 145 - 153
  • [7] Optimal management of non-functioning pituitary adenomas
    Greenman, Yona
    Stern, Naftali
    ENDOCRINE, 2015, 50 (01) : 51 - 55
  • [8] Management of patients with non-functioning pituitary adenomas
    Köbberling, J
    MEDIZINISCHE KLINIK, 2003, 98 (11) : 616 - 616
  • [9] Non-functioning pituitary adenomas
    Greenman, Yona
    Stern, Naftali
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 23 (05) : 625 - 638
  • [10] NON-FUNCTIONING PITUITARY ADENOMAS : A PLEA FOR AN EARLIER DIAGNOSIS
    Yvan, Zunon-Kipre
    Esperance, Broalet
    Landry, Drogba
    Aderehime, Haidara
    Herman, N'Da
    Vincent, Bazeze
    AFRICAN JOURNAL OF NEUROLOGICAL SCIENCES, 2007, 26 (02): : 83 - 94